Viewing Study NCT04062266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2026-01-31 @ 5:12 AM
Study NCT ID: NCT04062266
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-07
First Post: 2019-08-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia in Remission View
None FLT3 Gene Mutation View
None Hematologic and Lymphocytic Disorder View
None Acute Myeloid Leukemia View
None Minimal Residual Disease Persistence View
None Therapy-Related Acute Myeloid Leukemia View
Keywords: